Literature DB >> 22743177

Triiodothyronine supplementation and cytokines during cardiopulmonary bypass in infants and children.

James R Priest1, April Slee, Aaron K Olson, Dolena Ledee, Fionnuala Morrish, Michael A Portman.   

Abstract

OBJECTIVE: The Triiodothyronine Supplementation in Infants and Children Undergoing Cardiopulmonary Bypass (TRICC) study demonstrated a shortened time to extubation in children younger than 5 months old undergoing cardiopulmonary bypass for congenital heart surgery with triiodothyronine supplementation. Cardiopulmonary bypass precipitates a systemic inflammatory response that affects recovery, and triiodothyronine is related to cytokine mediators of inflammation. We sought to investigate the preoperative cytokine levels by age and relationship to the triiodothyronine levels and to examine the effect of the cytokine levels on the time to extubation.
METHODS: We measured 6 cytokines at preoperative time 0 and 6 and 24 hours after crossclamp removal in 76 subjects.
RESULTS: The preoperative cytokine levels were related to both the triiodothyronine levels and the patient age. The postoperative cytokine levels were predictive of the triiodothyronine levels at 6, 12, 24, and 72 hours. Preoperative CCL4 was associated with an increased chance of early extubation. Inclusion of the cytokines did not change the relationship of triiodothyronine to the time to extubation, and the postoperative course of interleukin-6 was independently associated with a decreased chance of early extubation.
CONCLUSIONS: The preoperative and postoperative cytokine levels, in particular, interleukin-1β, showed complex time-dependent relationships with triiodothyronine. The data suggest that cytokine-mediated suppression of triiodothyronine plays an important role in determining the clinical outcome after cardiopulmonary bypass.
Copyright © 2012 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22743177      PMCID: PMC5147421          DOI: 10.1016/j.jtcvs.2012.05.063

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  23 in total

1.  A review of four dreaded complications of open-heart operations. Causes, avoidance, and treatment of acidosis, overoxygenation, heart-block, and pulmonary damage.

Authors:  W J KOLFF; D B EFFLER; L K GROVES
Journal:  Br Med J       Date:  1960-04-16

Review 2.  Clinical review: Thyroid hormone therapy for postoperative nonthyroidal illnesses: a systematic review and synthesis.

Authors:  Elaine M Kaptein; Andrea Sanchez; Elizabeth Beale; Linda S Chan
Journal:  J Clin Endocrinol Metab       Date:  2010-07-28       Impact factor: 5.958

3.  Repression of cardiac phospholamban gene expression is mediated by thyroid hormone receptor-{alpha}1 and involves targeted covalent histone modifications.

Authors:  Madesh Belakavadi; Jason Saunders; Noah Weisleder; Preethi S Raghava; Joseph D Fondell
Journal:  Endocrinology       Date:  2010-04-14       Impact factor: 4.736

4.  Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits.

Authors:  M Fung; P G Loubser; A Undar; M Mueller; C Sun; W N Sun; W K Vaughn; C D Fraser
Journal:  J Thorac Cardiovasc Surg       Date:  2001-07       Impact factor: 5.209

5.  Cytokine balance in infants undergoing cardiac operation.

Authors:  Hedwig H Hövels-Gürich; Kathrin Schumacher; Jaime F Vazquez-Jimenez; Ma Qing; Ulrike Hüffmeier; Brigitte Buding; Bruno J Messmer; Götz von Bernuth; Marie-Christine Seghaye
Journal:  Ann Thorac Surg       Date:  2002-02       Impact factor: 4.330

6.  Interleukin-6 and thyroid hormone metabolism in pediatric cardiac surgery patients.

Authors:  Clarie K McMahon; Irwin Klein; Kaie Ojamaa
Journal:  Thyroid       Date:  2003-03       Impact factor: 6.568

7.  Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study.

Authors:  Alessandro Pingitore; Elena Galli; Andrea Barison; Annalisa Iervasi; Maria Scarlattini; Daniele Nucci; Antonio L'abbate; Rita Mariotti; Giorgio Iervasi
Journal:  J Clin Endocrinol Metab       Date:  2008-01-02       Impact factor: 5.958

Review 8.  Prophylactic steroids for pediatric open heart surgery.

Authors:  S Robertson-Malt; B Afrane; M El Barbary
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

Review 9.  Pediatric cardiopulmonary bypass circuits: a review of studies conducted at the Penn State Pediatric Cardiac Research Laboratories.

Authors:  Akemi Miller; Chiajung Karen Lu; Shigang Wang; Todd M Umstead; Willard M Freeman; Kent Vrana; Sung Yang; John L Myers; David S Phelps; Jeffrey D Zahn; Akif Undar
Journal:  J Extra Corpor Technol       Date:  2009-03

Review 10.  Off-pump versus on-pump coronary artery bypass grafting: a systematic review and meta-analysis of propensity score analyses.

Authors:  Oliver Kuss; Benita von Salviati; Jochen Börgermann
Journal:  J Thorac Cardiovasc Surg       Date:  2010-02-18       Impact factor: 5.209

View more
  5 in total

1.  Triiodothyronine activates lactate oxidation without impairing fatty acid oxidation and improves weaning from extracorporeal membrane oxygenation.

Authors:  Masaki Kajimoto; Dolena R Ledee; Chun Xu; Hidemi Kajimoto; Nancy G Isern; Michael A Portman
Journal:  Circ J       Date:  2014-10-28       Impact factor: 2.993

2.  Cardiac and Pulmonary Histopathology in Baboons Following Genetically-Engineered Pig Orthotopic Heart Transplantation.

Authors:  Silvio H Litovsky; Jeremy B Foote; Abhijit Jagdale; Gregory Walcott; Hayato Iwase; Mohamed H Bikhet; Takayuki Yamamoto; Christophe Hansen-Estruch; Mohamed B Ezzelarab; David Ayares; Waldemar F Carlo; Leslie A Rhodes; Jack H Crawford; Santiago Borasino; Robert J Dabal; Luz A Padilla; Hidetaka Hara; David K C Cooper; David C Cleveland
Journal:  Ann Transplant       Date:  2022-07-05       Impact factor: 1.479

3.  Myocardial oxidative metabolism and protein synthesis during mechanical circulatory support by extracorporeal membrane oxygenation.

Authors:  Colleen M O'Kelly Priddy; Masaki Kajimoto; Dolena R Ledee; Bertrand Bouchard; Nancy Isern; Aaron K Olson; Christine Des Rosiers; Michael A Portman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-11-30       Impact factor: 4.733

4.  Cardioprotective effects of triiodothyronine supplementation against ischemia reperfusion injury by preserving calcium cycling proteins in isolated rat hearts.

Authors:  Lichao Fang; Zhiping Xu; Jian Lu; Lei Hong; Shigang Qiao; Lijun Liu; Jianzhong An
Journal:  Exp Ther Med       Date:  2019-10-21       Impact factor: 2.447

5.  Triiodothyronine facilitates weaning from extracorporeal membrane oxygenation by improved mitochondrial substrate utilization.

Authors:  Matthew D Files; Masaki Kajimoto; Colleen M O'Kelly Priddy; Dolena R Ledee; Chun Xu; Christine Des Rosiers; Nancy Isern; Michael A Portman
Journal:  J Am Heart Assoc       Date:  2014-03-20       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.